Previous 10 | Next 10 |
Co-Diagnostics Reports Strong Second Quarter 2021 Financial Results Solid quarterly results highlighted by revenue of $27.4 million, pre-tax income of $11.9 million and diluted EPS of $0.33 PR Newswire SALT LAKE CITY , Aug. 12, 2021 /PRNewswire/ -- Co-Di...
Co-Diagnostics, Inc. Announces Second Quarter 2021 Earnings Release Date And Webcast PR Newswire SALT LAKE CITY , Aug. 4, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the devel...
Are These The Best Medical Diagnostic Stocks To Buy Right Now? Medical diagnostic stocks are a branch of health care stocks in the stock market . As the name suggests, these are companies that specialize in diagnostic testing and equipment. The importance of a good diagnosis sho...
The roller-coaster-like trajectory that has been Co-Diagnostics ' (NASDAQ: CODX) stock price climbed another hill on Thursday. The healthcare-testing specialist's shares closed over 21% higher on the day, due largely to news of a fresh patent awarded to the company. Co-Diagnosti...
Co-Diagnostics ([[CODX]]) has been awarded a patent from the Republic of Korea's Intellectual Property Office for the company's CoPrimer technology.CoPrimer technology received its first patent from the United States Patent Office in 2018, and underpins the company's molecular diagnostic test...
Co-Diagnostics, Inc. Strengthens Intellectual Property Portfolio with New International CoPrimer™ Patent PR Newswire SALT LAKE CITY , July 22, 2021 /PRNewswire / -- Co-Diagnostics, Inc. (Nasdaq: CODX) , a molecular diagnostics company with a un...
Shares of a clutch of healthcare companies involved directly or tangentially in the fight against the coronavirus were doing very well on Monday. Moderna (NASDAQ: MRNA) , for one, was up by nearly 10% in midafternoon trading, while Co-Diagnostics (NASDAQ: CODX) was trailing ...
Co-Diagnostics ([[CODX]] +3.1%) announces that its Logix Smart SARS-CoV-2 DS (Direct Saliva) has obtained regulatory authorization to be sold as an in vitro diagnostic ("IVD") for the diagnosis of COVID-19 in markets that accept CE markings.The kit is designed to detect the presence of the Rd...
Co-Diagnostics, Inc Receives CE Marking for Direct Saliva SARS-CoV-2 Test PR Newswire SALT LAKE CITY , June 18, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) , a molecular diagnostics company with a unique, patented platform for the developmen...
Co-Diagnostics, Inc. to Present at Upcoming Technology and Health Research Conferences PR Newswire SALT LAKE CITY , June 15, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company"), a molecular diagnostics company with a unique, paten...
News, Short Squeeze, Breakout and More Instantly...
Co-Diagnostics, Inc. to Host Booth and Discuss Advancing POC/OTC Diagnostics at ADLM 2024 in Chicago PR Newswire SALT LAKE CITY , July 29, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company wi...
Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Release Date and Webcast PR Newswire SALT LAKE CITY , July 25, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the developme...
Co-Diagnostics, Inc. Expands Vector Control Customer Base to 25 Customers across 15 U.S. States PR Newswire SALT LAKE CITY , July 2, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx™"), a molecular diagnostics company w...